Life Science Leader Magazine October 2009 Contents The changing business of drug development: Boehringer - Ingelheim's top drug development exec talks about how today's R & D professionals have to do more with less and how they can adapt A biotech rebound? How to maximize your EDC solution Who will dominate biosimilars? Rethink you pharmacovigilance strategies New Item in photo is actual item you will receive Check out my other items! Thanks for stopping by!!

The free listing tool. List your items fast and easy and manage your active items.